围手术期液体管理与术后结局:20年随机目标导向治疗试验的系统评价与Meta分析
该系统评价与Meta分析纳入21项随机对照试验、共2729例接受大型内脏/非心脏手术的患者,比较目标导向治疗(GDT)与对照组的术后并发症和围手术期死亡率。围手术期液体输注量中位数为4500 ml;在低于或高于该阈值的亚组中,GDT与对照组的术后并发症差异均未达统计学显著(43.4% vs 34.2%,p=0.23;54.8% vs 39.8%,p=0.09)。总体GDT降低术后并发症总发生率(合并风险差=-0.10,95%CI -0.14~-0.07;Chi2=30.97;p<0.0001),但未降低围手术期死亡率(合并风险差=-0.016,95%CI -0.0334~0.0014;p=0.07)。GDT未减少肾脏(p=0.52)、心血管(p=0.86)、肺部(p=0.14)、神经(p=0.44)或感染(p=0.12)相关并发症。
要点
- 在21项RCT、2729例大型内脏/非心脏手术患者中,GDT总体降低术后并发症(合并风险差=-0.10,95%CI -0.14~-0.07;p<0.0001)。
- 围手术期液体中位量4500 ml,低于该阈值时GDT与对照组并发症为43.4% vs 34.2%(p=0.23),高于阈值时为54.8% vs 39.8%(p=0.09),均未达统计学显著。
- GDT未降低围手术期死亡率(合并风险差=-0.016,95%CI -0.0334~0.0014;p=0.07)。
- GDT未减少肾脏(p=0.52)、心血管(p=0.86)、肺部(p=0.14)、神经(p=0.44)或感染(p=0.12)相关术后并发症。
适用人群与场景
- 接受大型内脏/非心脏手术的患者,纳入比较GDT与对照组的随机对照试验。
研究设计与关键结果
- 系统评价与Meta分析纳入21项RCT、2729例患者,围手术期液体输注量中位数为4500 ml。
- 液体量低于4500 ml的亚组中,GDT与对照组术后并发症为43.4% vs 34.2%,p=0.23;高于4500 ml的亚组为54.8% vs 39.8%,p=0.09,均未达统计学显著。
- 总体GDT降低术后并发症总发生率:合并风险差=-0.10(95%CI -0.14~-0.07);Chi2=30.97;p<0.0001。
- GDT未降低围手术期死亡率:合并风险差=-0.016(95%CI -0.0334~0.0014);p=0.07。
- GDT未减少肾脏(p=0.52)、心血管(p=0.86)、肺部(p=0.14)、神经(p=0.44)或感染(p=0.12)相关术后并发症。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析,纳入21项随机对照试验(RCT)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,无论围手术期液体输注量多少,GDT策略可减少术后并发症,但不降低围手术期死亡率。
指南或共识出处
- PROSPERO注册号CRD42020168866,注册时间2020年2月。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Appropriate perioperative fluid management is of pivotal importance to reduce postoperative complications, which impact on early and long-term patient outcome. The so-called perioperative goal-directed therapy (GDT) approach aims at customizing perioperative fluid management on the individual patients' hemodynamic response. Whether or not the overall amount of perioperative volume infused in the context of GDT could influence postoperative surgical outcomes is unclear.
METHODS: We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) comparing the efficacy of GDT approach between study population and control group in reducing postoperative complications and perioperative mortality, using MEDLINE, EMBASE and the Cochrane Controlled Clinical trials register. The enrolled studies were grouped considering the amount infused intraoperatively and during the first 24 h after the admission in the critical care unit (perioperative fluid).
RESULTS: The metanalysis included 21 RCTs enrolling 2729 patients with a median amount of perioperative fluid infusion of 4500 ml. In the studies reporting an overall amount below or above this threshold, the differences in postoperative complications were not statically significant between controls and GDT subgroup [43.4% vs. 34.2%, p value = 0.23 and 54.8% vs. 39.8%; p value = 0.09, respectively]. Overall, GDT reduced the overall rate of postoperative complications, as compared to controls [pooled risk difference (95% CI) = - 0.10 (- 0.14, - 0.07); Chi2 = 30.97; p value < 0.0001], but not to a reduction of perioperative mortality [pooled risk difference (95%CI) = - 0.016 (- 0.0334; 0.0014); p value = 0.07]. Considering the rate of organ-related postoperative events, GDT did not reduce neither renal (p value = 0.52) nor cardiovascular (p value = 0.86) or pulmonary (p value = 0.14) or neurological (p value = 0.44) or infective (p value = 0.12) complications.
CONCLUSIONS: Irrespectively to the amount of perioperative fluid administered, GDT strategy reduces postoperative complications, but not perioperative mortality.
TRIAL REGISTRATION: CRD42020168866; Registration: February 2020 https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=168866.
参考来源
- Messina A, Robba C, Calabrò L, et al. Association between perioperative fluid administration and postoperative outcomes: a 20-year systematic review and a meta-analysis of randomized goal-directed trials in major visceral/noncardiac surgery. Crit Care. 2021. PMID: 33522953. doi:10.1186/s13054-021-03464-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。